Kotra Industries Bhd (XKLS:0002) Total Receivables: RM41.2 Mil (As of Mar. 2026)


XKLS:0002 Kotra Industries Bhd XKLS:0002
84 GF Score
Price RM3.72
GF Value RM4.34
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Kotra Industries Bhd Total Receivables?

Kotra Industries Bhd XKLS:0002 84 Total Receivables is RM41.2 Mil as of Mar. 2026. GuruFocus rates XKLS:0002 with a GF Score™ of 84/100 and a GF Value™ of RM4.34 (Modestly Undervalued). The stock has 2 warning signs investors should review.

Kotra Industries Bhd's Total Receivables for the quarter that ended in Mar. 2026 was RM41.2 Mil.

Kotra Industries Bhd Total Receivables Related Terms

Kotra Industries Bhd Total Receivables Historical Data

* Premium members only.

The historical data trend for Kotra Industries Bhd's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kotra Industries Bhd Total Receivables Chart

Kotra Industries Bhd Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Total Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 22.77 35.49 34.90 36.50 32.82

Kotra Industries Bhd Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 39.28 32.82 36.06 41.98 41.16
XKLS:0002
84GF Score
Kotra Industries Bhd XKLS:0002
Total Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kotra Industries Bhd Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Frequently Asked Questions Learn more about Total Receivables →
What does a Total Receivables of RM41.2 Mil mean?
Kotra Industries Bhd (XKLS:0002) has a Total Receivables of RM41.2 Mil as of Mar. 2026. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Kotra Industries Bhd and its competitors.
Is Kotra Industries Bhd's Total Receivables too high?
Kotra Industries Bhd's current Total Receivables is RM41.2 Mil. Overall, Kotra Industries Bhd has a GF Score™ of 84/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Kotra Industries Bhd's Total Receivables compare to ZTS and UTHR?
Kotra Industries Bhd's Total Receivables of RM41.2 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Receivables for a Drug Manufacturers company?
A good Total Receivables depends on the Drug Manufacturers industry context. However, Total Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Receivables mean?
A high Total Receivables can signal that a stock is expensive relative to its fundamentals. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Kotra Industries Bhd and its competitors. Kotra Industries Bhd's current Total Receivables is RM41.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kotra Industries Bhd stock overvalued right now?
Based on GuruFocus' analysis, Kotra Industries Bhd (XKLS:0002) is currently considered Modestly Undervalued. The stock's GF Value™ is RM4.34, compared to a current price of RM3.72 — trading 14.3% below its estimated fair value. The current Total Receivables is RM41.2 Mil. Kotra Industries Bhd's overall GF Score™ is 84/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Receivables calculated?
Total Receivables is calculated from a company's financial statements. For Kotra Industries Bhd (XKLS:0002), the current Total Receivables is RM41.2 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Kotra Industries Bhd (XKLS:0002) Overvalued in 2026?

Based on GuruFocus' analysis, Kotra Industries Bhd stock appears to be undervalued. The current stock price of RM3.72 is trading 14.3% below its estimated GF Value™ of RM4.34. GuruFocus considers Kotra Industries Bhd to be Modestly Undervalued.

Key valuation signals for XKLS:0002:

  • Total Receivables: RM41.2 Mil
  • GF Value™: RM4.34 vs. price of RM3.72 (14.3% below fair value)
  • GF Score™: 84/100 with 2 warning signs

No single metric tells the full story. See the XKLS:0002 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Kotra Industries Bhd Business Description

Address Jalan TTC 12, No. 1, 2 & 3, Cheng Industrial Estate, Melaka, MYS, 75250
Kotra Industries Bhd is a Malaysian pharmaceutical company engaged in the development, manufacturing, and supply of pharmaceutical and healthcare products supporting all life stages. Its portfolio includes life-saving medicines, OTC supplements, and nutrition products. The Group markets three core brands: Appeton, offering health supplements and nutrition across all age groups; Vaxcel, providing injectable medicines for infectious diseases, kidney care, and gastroenterology; and Axcel, specializing in oral and topical medicines for paediatrics, dermatology, and infectious diseases. The company operates in Malaysia and overseas, with the majority of revenue derived from Malaysia.
84GF Score

Get the complete analysis for XKLS:0002

Total Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

RM3.72
Price
RM4.34
GF Value